Matrix metalloproteinase 9: An emerging biomarker for classification of adherent vestibular schwannoma.

Han T N NguyenBailey H DuhonHsuan-Chih KuoMelanie FisherOlivia M BrickeyLisa ZhangJose J OteroDaniel M PrevedelloOliver F AdunkaYin Ren

Published in: Neuro-oncology advances (2024)

We identify MMP9 as a preoperative biomarker to classify adherent VS. MMP9 may represent a new therapeutic target in adherent VS associated with poor surgical outcomes that lack other viable treatment options.

Keyphrases

machine learning
cell migration
deep learning
patients undergoing